Filed: 8/14/2025ACC: 0000950123-25-008264
📋 What this filing means
MWG MANAGEMENT LTD. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $51.90M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$51.90M
Total AUM (reported)
5.07M
Total Shares
Allocation by class
COM$51.90M100.0%
Portfolio Concentration
Top 3$51.90M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 5.07M
Sole
Full voting authority
5.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other3
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
BEAM THERAPEUTICS INC
DFNDShares2.27M
TypeSH
Market value$38.56M
74.30%
Sole
2.27M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
DFNDShares1.01M
TypeSH
Market value$8.91M
17.17%
Sole
1.01M
Shared
0.00
None
0.00
PRIME MEDICINE INC
DFNDShares1.79M
TypeSH
Market value$4.43M
8.53%
Sole
1.79M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BEAM THERAPEUTICS INCDFND | COM | 2.27M | SH | $38.56M 74.30% | 2.27M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCDFND | COM | 1.01M | SH | $8.91M 17.17% | 1.01M | 0.00 | 0.00 |
PRIME MEDICINE INCDFND | COM | 1.79M | SH | $4.43M 8.53% | 1.79M | 0.00 | 0.00 |